Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aeolus Pharmaceuticals Inc (OTCQB:AOLS)

0.2398
Delayed Data
As of 10:58am ET
 +0.0099 / +4.31%
Today’s Change
0.19
Today|||52-Week Range
0.55
+4.26%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues4.8M7.3M3.9M9.6M
 
 
 
 
 
Depreciation And Amortization5.0K7.0K6.0K0.00
 
 
 
 
 
Operating ExpensesGross Income------9.6M
 
 
General Expenses8.7M9.7M6.6M9.7M
 
 
 
 
 
Research And Development5.1M6.5M3.4M7.0M
 
 
 
 
 
Total Operating Expenses8.7M9.7M6.6M9.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.9M-2.4M-2.7M-80.0K
 
 
 
 
 
Extraordinary Credit3.9M4.1M0.000.00
 
 
 
Extraordinary Charge0.000.00-510.0K0.00
 
 
Interest Expense On Debt21.0K0.000.000.00
 
 
Other Expenses335.0K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income299.0K1.7M-3.2M-80.0K
 
 
 
 
 
Net Income299.0K1.7M-3.2M-80.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS59.5M61.6M106.6M134.7M
 
 
 
 
 
Shares To Calculate EPS Diluted82.3M72.7M106.6M134.7M
 
 
 
 
 
 
Earnings Per ShareEPS--$0.02-$0.03$0.00
 
 
 
EPS Diluted$0.00$0.02-$0.03-$0.00